Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/33236

Título:

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Otros títulos:

Coordinador:

Director:

Compilador:

Autor:

Niborski, Leticia L.
Potenza, Mariana
Chirivi, Renato G. S.
Simonetti, Leandro
Ossowski, Micaela S.
Grippo, Vanina
May, Maria
Staquicini, Daniela I.
Parodi-Tálice, Adriana Magdalena
Robello Porto, Carlos
Comini, Marcelo A.
Alonso, Guillermo D.
Raats, Jos M.H.
Gómez, Karina A.

Tutor:

Tipo de documento:

Artículo

Editor:

Palabras clave:

Chagas disease
Phage-display
Tubulin
Molecular mimicry
Post-translational modification
Digestive system

Descriptores:

Año de publicación:

2021

Contenido:

Resumen:

Background: To deeply understand the role of antibodies in the context of Trypanosoma cruzi infection, we decided to characterize A2R1, a parasite antibody selected from single-chain variable fragment (scFv) phage display libraries constructed from B cells of chronic Chagas heart disease patients. Methods: Immunoblot, ELISA, cytometry, immunofluorescence and immunohistochemical assays were used to characterize A2R1 reactivity. To identify the antibody target, we performed an immunoprecipitation and two-dimensional electrophoresis coupled to mass spectrometry and confirmed A2R1 specific interaction by producing the antigen in different expression systems. Based on these data, we carried out a comparative in silico analysis of the protein target_s orthologues, focusing mainly on post-translational modifications. Findings: A2R1 recognizes a parasite protein of ~50 kDa present in all life cycle stages of T. cruzi, as well as in other members of the kinetoplastid family, showing a defined immunofluorescence labeling pattern consistent with the cytoskeleton. A2R1 binds to tubulin, but this interaction relies on its post-translational modifications. Interestingly, this antibody also targets mammalian tubulin only present in brain, staining in and around cell bodies of the human peripheral and central nervous system. Interpretation: Our findings demonstrate for the first time the existence of a human antibody against T. cruzi tubulin capable of cross-reacting with a human neural protein. This work re-emphasizes the role of molecular mimicry between host and parasitic antigens in the development of pathological manifestations of T. cruzi infection.

Descripción:

metadata.articulos.dc.description.uri:

Editorial:

The Lancet

EN:

eBioMedicine, 2021, 63: 103206.

Financiadores:

Citación:

Niborski, L, Potenza, M, Chirivi, R [y otros autores]. "Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system". eBioMedicine. [en línea] 2021, 63: 103206. 15 h. Doi: 10.1016/j.ebiom.2020.103206.

Citación:

metadata.articulos.cc.license.name:

ISBN:

e-ISBN:

ISSN:

2352-3964

ISMN:

Otros identificadores:

Cobertura geográfica:

Cobertura temporal:

Departamento académico:

Grupo de investigación:

Licencia:

Licencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0)
FicherosDescripciónTamañoFormato
101016jebiom2020103206.pdf — 4.52 MB Adobe PDF